If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research interests

Dr. Timothy Craig has been a clinical researcher for more than 23 years and has participated in NHLBI asthma research consortiums, including ACRN and AsthmaNet. He is a leader in the field of allergy and immunology and has written guidelines for international management of urticaria, hereditary angioedema and rhinitis. He has more than 300 publications and around 400 invited lectures.

His clinical research and clinical care focuses include asthma, COPD, alpha-1-antitrypsin deficiency, urticaria, hereditary angioedema, immunodeficiency, vaccine response and other respiratory, allergic and immunologic diseases. Dr. Craig directs the Penn State Alpha-1 Deficiency Center; the Allergy, Asthma and Immunology Fellowship; the Respiratory Allergy and Immunology Clinical Research Center; and the Section of Allergy, Asthma and Immunology in the Division of Pulmonary, Allergy and Critical Care Medicine.

Dr. Craig works with collaborators in Vietnam, Cornell University and elsewhere in Penn State to study respiratory and allergic diseases. His collaborations with basic researchers in asthma include a mouse model to study how asthma affects anxiety and a mouse model to assess microbiome influence on asthma.


Teaching and educational interests

Dr. Timothy Craig's teaching interest includes the mentoring of medical students, residents and fellows. He is a Penn State College of Medicine Distinguished Educator and recently established a site in Vietnam (Lam Dong Medical College in Dalat, Vietnam) to train Penn State medical students in global health. He mentors and hosts many international students.

Education/Academic qualification

Internal Medicine, Residency, Naval Medical Center San Diego

DO, New York College Osteopathic Medicine

Allergy and Immunology, Fellowship, Walter Reed Army Medical Center

External positions

Board member, American Association of Allergy, Asthma and Immunology

Board member, Mid-Atlantic States, American Lung Association

Medical Advisory Board member, US Hereditary Angioedema Association

Fingerprint Dive into the research topics where Timothy Craig is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 3 Similar Profiles
Hereditary Angioedemas Medicine & Life Sciences
Asthma Medicine & Life Sciences
Complement C1 Inhibitor Protein Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Angioedema Medicine & Life Sciences
Adrenal Cortex Hormones Medicine & Life Sciences
Nose Medicine & Life Sciences
Sleep Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1991 2019

3 Citations (Scopus)

A review of kallikrein inhibitor lanadelumab in hereditary angioedema

Hwang, G., Johri, A., Ng, S. & Craig, T., Jan 1 2019, In : Immunotherapy. 11, 11, p. 937-943 7 p.

Research output: Contribution to journalArticle

Hereditary Angioedemas

Burden of Asthma and Role of 2.5 µg Tiotropium Respimat® as an Add-On Therapy: A Systematic Review of Phase 2/3 Trials

Mansfield, L., Duong-Quy, S. & Craig, T., Oct 1 2019, In : Advances in Therapy. 36, 10, p. 2587-2599 13 p.

Research output: Contribution to journalReview article

Open Access
Adrenal Cortex Hormones
1 Citation (Scopus)

Clinical profile and quality of life of Puerto Ricans with hereditary angioedema

Arce-Ayala, Y. M., Diaz-Algorri, Y., Craig, T. & Ramos-Romey, C., Jan 1 2019, In : Allergy and Asthma Proceedings. 40, 2, p. 103-110 8 p.

Research output: Contribution to journalArticle

Hereditary Angioedemas
Hispanic Americans
Quality of Life
Puerto Rico
Hereditary Angioedema Types I and II
1 Citation (Scopus)

Drug-induced severe cutaneous adverse reactions: Determine the cause and prevention

Zhang, C., Van, D. N., Hieu, C. & Craig, T., Nov 2019, In : Annals of Allergy, Asthma and Immunology. 123, 5, p. 483-487 5 p.

Research output: Contribution to journalArticle

Stevens-Johnson Syndrome
Acute Generalized Exanthematous Pustulosis
Pharmaceutical Preparations

Fixed-Dose Subcutaneous C1-Inhibitor Liquid for Prophylactic Treatment of C1-INH-HAE: SAHARA Randomized Study

SAHARA study group, May 1 2019, In : Journal of Allergy and Clinical Immunology: In Practice. 7, 5, p. 1610-1618.e4

Research output: Contribution to journalArticle

Open Access
Hereditary Angioedemas
Hereditary Angioedema Types I and II